Skip to main content
Clinical Trials/NCT06488690
NCT06488690
Completed
Not Applicable

Effectiveness of Early Warning Scores: Preoperative Period in Pregnant Women

Suleyman Demirel University1 site in 1 country304 target enrollmentApril 1, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pregnancy Complications
Sponsor
Suleyman Demirel University
Enrollment
304
Locations
1
Primary Endpoint
MEWT score
Status
Completed
Last Updated
last year

Overview

Brief Summary

Our study aims to evaluate the use of early warning scores as a screening tool to predict obstetric mortality and morbidity in pregnant women who will undergo cesarean section.

Detailed Description

Our study aims to evaluate the use of early warning scores as a screening tool to predict obstetric mortality and morbidity in pregnant women who will undergo cesarean section. This prospective study included 304 patients undergoing cesarean section at Suleyman Demirel University between April 2022 and April 2023. Physiological parameters were assessed in all 304 pregnant women before the operation. Maternal early warning scores, including modified early obstetric warning score (MEOWS), maternal early warning score (MEWC), and maternal early warning triggers (MEWT), were calculated for each patient. Patients triggering the system were classified as Group 1 (risky patients), while those not triggering the system were classified as Group 2 (risk-free patients).

Registry
clinicaltrials.gov
Start Date
April 1, 2022
End Date
February 1, 2024
Last Updated
last year
Study Type
Interventional
Study Design
Sequential
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Onurcan BALIK

Doctor

Suleyman Demirel University

Eligibility Criteria

Inclusion Criteria

  • All patients who are pregnant and undergo cesarean section

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

MEWT score

Time Frame: One year

For MEWT, the presence of a "trigger" defined as either a single severely abnormal parameter (falling in the "red" zone) or two mildly abnormal parameters (falling in the "yellow" zone) was categorized as the risky group, with the absence or mildness of the trigger considered as the risk-free group.

MEOWS, MEWC and MEWT scores

Time Frame: One year

The presence of a "trigger" for MEOWS in all systems, defined as either a single severely abnormal parameter (falling in the "red" zone) or two slightly abnormal parameters (falling in the "yellow" zone), was categorized as the risky group. Absence or mildness of the trigger was considered as the risk-free group.

MEWC score

Time Frame: One year

In the case of MEWC, the presence of only one abnormal parameter designated the risk group, while the absence of a trigger indicated the risk-free group.

Secondary Outcomes

  • Aldrete score(One year)
  • APGAR score(One year)
  • Glasgow Coma Scale(One year)

Study Sites (1)

Loading locations...

Similar Trials